What it sells
Patent-pending enzymes to break down common dietary triggers
Business model breakdown
Buyer: who owns the budget?
UnverifiedIndividual consumers (HSA/FSA eligible); clinicians as recommenders.
Trigger: what makes them buy now?
Digestive symptoms after eating garlic, onion, wheat, beans or dairy; wanting to avoid strict low-FODMAP diets.
Workflow: what inputs become what output?
UnverifiedCustomer applies enzyme blend to meals before eating so triggers are broken down; can subscribe for repeat supply.
Economics: what it saves and how it charges
Consumer DTC product with subscription option and money-back guarantee, free US shipping.
Distribution: how it reaches customers
DTC Shopify store, subscriptions, clinician partner program (providers.fodzyme.com), international country storefronts.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.